Clinical trial
A Study to Evaluate the Efficacy and Tolerability of Clobetasol Propionate vs. Vehicle in the Treatment of Mild to Moderate Plaque-Type Psoriasis
NCT00842153 is registered in ClinicalTrials.gov with Stiefel, a GSK Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Efficacy and Tolerability of Clobetasol Propionate vs. Vehicle in the Treatment of Mild to Moderate Plaque-Type Psoriasis
- Lead sponsor
- Stiefel, a GSK Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- January 31, 2008
- Enrollment
- 58 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.